Pay in 4 interest-free payments of $6.23 Learn more
Ships within 48 hours · Estimated delivery Oct 2 - Oct 7
As of October 2019, MT-I is approved by the United States Food and Drug Administration (FDA) under the brand name Scenesse for increasing tolerance to sunlight and reducing pain caused by ultraviolet light (UV-light) exposure in patients with erythropoietic protoporphyria (EPP)
Kojic Acid: Kojic acid is known for its skin-lightening effect as it may block the formation of melanin
.png)
Methylcobalamin (B12) provides antioxidant protection that slows the oxidative degradation pathway heat accelerates
ABOM, ABIHM
US$ 20.71
US$ 29.67
US$ 25.75
US$ 26.37
US$ 20.26
US$ 20.90
US$ 26.08
US$ 24.17
